Literature DB >> 19386441

Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.

Amélie Monteau1, Brigitte Sigal-Zafrani, Youlia M Kirova, Virginie Fourchotte, Marc A Bollet, Anne Vincent-Salomon, Bernard Asselain, Remy J Salmon, Alain Fourquet.   

Abstract

PURPOSE: Following breast-conserving surgery for DCIS, reexcision before radiotherapy is recommended when margins are close or involved. We investigated whether an additional radiation dose could replace reexcision.
METHODS: We selected 208 women with DCIS of the breast treated with breast-conserving surgery between 1992 and 2002 who had either close margins (< 2 mm) (89 pts) or focally (< 1 mm) or minimally (1-15 mm) involved margins (119 pts). Sixty-one patients (29%) underwent reexcision before irradiation and 147 patients (71%) received breast irradiation with boost, without reexcision.
RESULTS: Median follow-up was 89 months. Median age was 53 years with 7 patients less than 41. Involved margins were less frequent in the non reexcision group than in the reexcised group (50% vs. 74%, p = 0.0019). All other clinical and histological features were comparable. Median whole-breast radiation dose was 50 Gy. Median total doses to the tumour bed were 67 Gy (range, 45-77) and 60 Gy (range, 46-74), respectively (p < 0.0001). Of the 61 reexcised patients, 56% had residual DCIS and 6% had invasive cancer. Six underwent a mastectomy for persistent margin involvement. Seven-year locoregional failure rates were 9.3% without, and 9.6% with reexcision (ns). No differences were observed when adjusting for margin status.
CONCLUSION: In carefully selected patients with close (< 2 mm) or focally/minimally involved margins, reexcision may be avoided and satisfactory local control achieved by increasing the radiation dose to the tumour bed to at least 66 Gy. These results only apply to patients older than 40 and would need confirmation in independent series.

Entities:  

Mesh:

Year:  2009        PMID: 19386441     DOI: 10.1016/j.ijrobp.2008.12.014

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective.

Authors:  Nina Bijker; Geertjan van Tienhoven
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.

Authors:  M J Cambra; F Moreno; X Sanz; L Anglada; M Mollà; V Reyes; M Arenas; A Pedro; R Ballester; V García; J Casals; M Cusidó; C Jimenez; J M Escribà; M Macià; J M Solé; A Arcusa; M A Seguí; S Gonzalez; B Farrús; A Biete
Journal:  Clin Transl Oncol       Date:  2019-07-01       Impact factor: 3.405

Review 3.  Radiotherapy of Ductal Carcinoma In Situ.

Authors:  David Krug; Rainer Souchon
Journal:  Breast Care (Basel)       Date:  2015-08-19       Impact factor: 2.860

4.  Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy.

Authors:  Meena S Moran; Yinjun Zhao; Shuangge Ma; Youlia Kirova; Alain Fourquet; Peter Chen; Karen Hoffman; Kelly Hunt; Julia Wong; Lia M Halasz; Gary Freedman; Robert Prosnitz; Michael Yassa; David H A Nguyen; Tarek Hijal; Bruce G Haffty; Elaine S Wai; Pauline T Truong
Journal:  JAMA Oncol       Date:  2017-08-01       Impact factor: 33.006

5.  Radiotherapy after conservative surgery in ductal carcinoma in situ of the breast: a review.

Authors:  Maurizio Amichetti; Cristiana Vidali
Journal:  Int J Surg Oncol       Date:  2012-05-13

Review 6.  Current view on ductal carcinoma in situ and importance of the margin thresholds: A review.

Authors:  A Van Cleef; S Altintas; M Huizing; K Papadimitriou; P Van Dam; W Tjalma
Journal:  Facts Views Vis Obgyn       Date:  2014

7.  Role of the radiotherapy boost on local control in ductal carcinoma in situ.

Authors:  Olivier Riou; Claire Lemanski; Vanessa Guillaumon; Olivier Lauche; Pascal Fenoglietto; Jean-Bernard Dubois; David Azria
Journal:  Int J Surg Oncol       Date:  2012-04-08

8.  Educational Case: Ductal Carcinoma In Situ (DCIS).

Authors:  Miglena K Komforti; Bryan E Harmon
Journal:  Acad Pathol       Date:  2019-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.